COVID -19
169
12
22
95
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Published Results
12 trials with published results (7%)
Research Maturity
95 completed trials (56% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.6%
6 terminated out of 169 trials
94.1%
+7.5% vs benchmark
7%
12 trials in Phase 3/4
13%
12 of 95 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 95 completed trials
Clinical Trials (169)
A Safety, Reactogenicity and Immunogenicity Trial of RVX-sCPD9 Booster Intranasal COVID-19 Vaccine
Assessment of Stress and Associated Factors Among Young Adults During the COVID-19 Pandemic
Effect of Surgical Masks in Preventing Acute Respiratory Infections
A Study to Explore the Role of Gut Flora in COVID-19 Infection
RSV, Influenza, and SARS-CoV-2 Outcomes in Severely Immunosuppressed Adults
Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study
A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19.
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ALG-097558 in Subjects With Renal Impairment and in Healthy Subjects With Normal Renal Function
Surveillance, Assessment and Detection of Influenza Associated Respiratory Infections in HIV Positive and Negative Individual in Lusaka, Zambia.
Feasibility of a Tele-game-based Exercise (Tele-exergame) Program to Prevent Deconditioning in Hospitalized COVID-19 Patients
Virological Surveillance of Acute Respiratory Infection in Primary Health Care in Metropolitan France
A Phase 1 Study to Evaluate the Safety and Immunogenicity of GC4006A in Healthy Adults
Effect of COV2 Vaccine Formulation on the Ability to Generate Antibodies Against Coronavirus That Causes COVID-19
The Efficacy of Long-Chain Fatty Acids, Eicosapentaenoic Acid (EPA) and Specialized Pro-Resolving Mediators (SPMs), in Treating Long COVID Neuropsychiatric Symptoms
Dapagliflozin for Long COVID Syndrome
French Single Centre Experience of Critically Ill Patients With Covid 19
Cohort Study of Intraoperative Lung Protective Ventilation Trends in a Large Canadian Health Authority
Retail COVID-19 Study
Diagnostic Accuracy of 2 cm Versus 4 cm Insertion Depth for Nasal Swabs for SARS-CoV-2 (COVID-19) Rapid Antigen Testing-A Randomized Controlled Trial
Analysis of Suicidal Behavior Among Children and Adolescents in the Auvergne-Rhone-Alpes Region During the Covid 19 Pandemic Period